Effects of S-1 as a second-line chemotherapy for patients with relapsed pancreatic cancer.
Ishido K, Toyoki Y, Kudo D, Kimura N, Yamana D, Miura T, Tsutsumi S, Muroya T, Yoshikawa T, Ogasawara H, Yonaiyama S, Narumi S, Hakamada K.
Ishido K, et al.
Oncol Lett. 2011 Nov;2(6):1313-1317. doi: 10.3892/ol.2011.412. Epub 2011 Sep 5.
Oncol Lett. 2011.
PMID: 22848308
Free PMC article.